5-MTHF

Research Reliability -

The bioactive form of folate that supports methylation, mood, prenatal health, and cardiovascular function.

Appetite

Mood

Sleep

5-MTHF
5-MTHF

Description

5-MTHF (methyltetrahydrofolate) is the active, ready-to-use form of folate that bypasses the MTHFR enzyme conversion step required by synthetic folic acid. It is essential for single-carbon metabolism, DNA synthesis, and neurotransmitter production. Individuals with MTHFR polymorphisms cannot efficiently convert folic acid and should use this form. It is critical during pregnancy for neural tube development, and supports homocysteine regulation, mood stability, and cardiovascular health across all life stages.

Effects
First 2 weeks

subtle

Weeks 2–4

for those who do not process folic acid well, mood and energy may lift

for those who do not process folic acid well, mood and energy may lift

Ongoing

methylation and homocysteine support

methylation and homocysteine support

How It Feels

Most people feel little. Those with an MTHFR variant sometimes notice a real mood or energy shift, since this is the already-active form of folate. A small subset feels wired or irritable, which signals the dose is too high.

Evidence

Evidence Strength

Moderate (some human RCTs)

Caveats

Best-supported as an adjunct in specific depression/deficiency contexts, not as a general cognitive enhancer.

Usage
Commonly Referenced Starting Amount

400 mcg DFE/day

Commonly Referenced Amount

400–1,000 mcg DFE/day covers RDA through commonly supplemented doses

Referenced Upper Limit

1,000 mcg/day is the IOM upper limit, set on synthetic folic acid's risk of masking B12 deficiency; methylfolate is presumed to carry a similar caution

Onset

2–4 weeks

Biomarkers to Track
Subjective

(Daily)

  1. Mood and emotional resilience

  2. Energy and mental clarity (1–10)

  3. Sleep quality score

Objective

(Quarterly)

  1. Homocysteine level

  2. RBC folate level

  3. MTHFR genotype (once, baseline)

Risks
Risks
Risks

Generally safe as the active folate form. A subset feels wired or irritable, a sign of overmethylation.

Who Should Skip
Who Should Skip
Who Should Skip

People on certain chemotherapy or seizure medications should check first.

Common Mistakes
Common Mistakes
Common Mistakes

Starting at a high dose rather than easing in, and ignoring irritability as a cue to lower it.

Disclaimer

This information is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.

Citations
Citations
Citations

Papakostas GI et al. (2012). American Journal of Psychiatry. RCT (L-methylfolate as antidepressant adjunct). PMID: 23212058.

The content on this site is provided for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. Aambrosia sells subscription access to editorial and research content only, no supplement, compound, or other physical product discussed on this site is sold, shipped, or dispensed by Aambrosia. Always consult a qualified healthcare provider before making changes to your diet, supplement routine, or health practices. Aambrosia does not guarantee specific results, and individual outcomes may vary

Business Address: Dunn Dr, Culver City, CA, 90232
Support: support@aambrosia.com